About Kane Biotech
Kane Biotech is a company based in Winnipeg (Canada) founded in 2001.. Kane Biotech offers products and services including revyve Antimicrobial Wound Gel, DermaKB Shampoo, and DermaKB Scalp Detoxifier. Kane Biotech operates in a competitive market with competitors including Imbed Biosciences, Cresilon, Alafair Biosciences, Lohmann & Rauscher and Nanordica Medical, among others.
- Headquarter Winnipeg, Canada
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Kane Biotech Inc.
-
Annual Revenue
$1.45 M (USD)1296.75as on Dec 31, 2024
-
Net Profit
$-2.1 M (USD)39.92as on Dec 31, 2024
-
EBITDA
$-2.97 M (USD)-19.28as on Dec 31, 2024
-
Latest Funding Round
$508 K (USD), Post-IPO
Dec 18, 2025
-
Investors
National Research Council Canada
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Kane Biotech
Kane Biotech is a publicly listed company on the TSXV with ticker symbol KNE in Canada, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Kane Biotech
Kane Biotech offers a comprehensive portfolio of products and services, including revyve Antimicrobial Wound Gel, DermaKB Shampoo, and DermaKB Scalp Detoxifier. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Gel that prevents biofilms and aids wound healing.
Shampoo to break down biofilms for scalp conditions.
Detoxifier targeting biofilms in common scalp issues.
Unlock access to complete
Unlock access to complete
Funding Insights of Kane Biotech
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $507,999
-
First Round
First Round
(14 May 2009)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Post-IPO - Kane Biotech | Valuation |
investors |
|
| May, 2025 | Amount | Post-IPO - Kane Biotech | Valuation |
investors |
|
| Jan, 2025 | Amount | Post-IPO - Kane Biotech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kane Biotech
Kane Biotech has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include National Research Council Canada, Canadian Space Agency and MTEC. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canadian space agency focused on social and economic benefits
|
Founded Year | Domain | Location | |
|
Medical technologies are advanced for military and civilian health.
|
Founded Year | Domain | Location | |
|
Scientific and technological research is conducted for Canada's benefit.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kane Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Kane Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kane Biotech Comparisons
Competitors of Kane Biotech
Kane Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Cresilon, Alafair Biosciences, Lohmann & Rauscher and Nanordica Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanotech-based wound care products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic products for wound care
|
|
| domain | founded_year | HQ Location |
Biomaterials and devices for internal wound healing are developed.
|
|
| domain | founded_year | HQ Location |
Dressing materials and medical devices
|
|
| domain | founded_year | HQ Location |
Nanotech-based antibacterial nanoparticles for wound dressings are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kane Biotech
Frequently Asked Questions about Kane Biotech
When was Kane Biotech founded?
Kane Biotech was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Where is Kane Biotech located?
Kane Biotech is headquartered in Winnipeg, Canada. It is registered at Winnipeg, Manitoba, Canada.
Who is the current CEO of Kane Biotech?
Mark Ahrens Townsend is the current CEO of Kane Biotech.
What is the annual revenue of Kane Biotech?
Annual revenue of Kane Biotech is $1.45M as on Dec 31, 2024.
What does Kane Biotech do?
Founded in 2001 and based in Winnipeg, Canada, Kane Biotech operates in the biotechnology sector. Focus is placed on developing therapeutic solutions to prevent and remove biofilms. Products such as ALEDEX, an antimicrobial composition for medical device coatings, animal care, and food processing, are offered. DispersinB, an antibiofilm enzyme for wound care, medical devices, and oral care, is included alongside StrixNB for animal drinking water and KBI Antibacterial Disinfectant.
Who are the top competitors of Kane Biotech?
Kane Biotech's top competitors include Imbed Biosciences, Cresilon and Lohmann & Rauscher.
What products or services does Kane Biotech offer?
Kane Biotech offers revyve Antimicrobial Wound Gel, DermaKB Shampoo, and DermaKB Scalp Detoxifier.
Is Kane Biotech publicly traded?
Yes, Kane Biotech is publicly traded on TSXV under the ticker symbol KNE.
Who are Kane Biotech's investors?
Kane Biotech has 3 investors. Key investors include National Research Council Canada, Canadian Space Agency, and MTEC.
What is Kane Biotech's ticker symbol?
The ticker symbol of Kane Biotech is KNE on TSXV.